Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia
Koichi Oshima, Hossein Khiabanian, Ana C. da Silva-Almeida, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 40, pp. 11306-11311
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

The genetics and molecular biology of T-ALL
Tiziana Girardi, Carmen Vicente, Jan Cools, et al.
Blood (2017) Vol. 129, Iss. 9, pp. 1113-1123
Open Access | Times Cited: 322
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia
Benshang Li, Samuel W. Brady, Xiaotu Ma, et al.
Blood (2019) Vol. 135, Iss. 1, pp. 41-55
Open Access | Times Cited: 235
Diagnosis and classification of hematologic malignancies on the basis of genetics
Justin Taylor, Wenbin Xiao, Omar Abdel‐Wahab
Blood (2017) Vol. 130, Iss. 4, pp. 410-423
Open Access | Times Cited: 212
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
Yu Zhu, Zi Wang, Yanan Li, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1219-1219
Open Access | Times Cited: 51
Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
Esmé Waanders, Zhaohui Gu, Stephanie M. Dobson, et al.
Blood Cancer Discovery (2020) Vol. 1, Iss. 1, pp. 96-111
Open Access | Times Cited: 114
Clonal evolution in leukemia
Adolfo A. Ferrando, Carlos López‐Otín
Nature Medicine (2017) Vol. 23, Iss. 10, pp. 1135-1145
Closed Access | Times Cited: 107
T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies
Valentina Cordoʹ, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, et al.
Blood Cancer Discovery (2020) Vol. 2, Iss. 1, pp. 19-31
Open Access | Times Cited: 102
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia
Gannie Tzoneva, Chelsea L. Dieck, Koichi Oshima, et al.
Nature (2018) Vol. 553, Iss. 7689, pp. 511-514
Open Access | Times Cited: 101
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
Isabel S. Jerchel, Alex Q. Hoogkamer, Ingrid M. Ariës, et al.
Leukemia (2017) Vol. 32, Iss. 4, pp. 931-940
Open Access | Times Cited: 96
New Approaches to the Management of Adult Acute Lymphoblastic Leukemia
Renato Bassan, Jean‐Pierre Bourquin, Daniel J. DeAngelo, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 35, pp. 3504-3519
Open Access | Times Cited: 89
Next-Generation Sequencing in Acute Lymphoblastic Leukemia
Nicoletta Coccaro, Luisa Anelli, Antonella Zagaria, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 2929-2929
Open Access | Times Cited: 86
Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs
Stephanie M. Dobson, Laura García‐Prat, Robert Vanner, et al.
Cancer Discovery (2020) Vol. 10, Iss. 4, pp. 568-587
Open Access | Times Cited: 85
Metabolic dependencies and vulnerabilities in leukemia
Marissa Rashkovan, Adolfo A. Ferrando
Genes & Development (2019) Vol. 33, Iss. 21-22, pp. 1460-1474
Open Access | Times Cited: 81
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance
Juan Martín Arriaga, Sukanya Panja, Mohammed Alshalalfa, et al.
Nature Cancer (2020) Vol. 1, Iss. 11, pp. 1082-1096
Open Access | Times Cited: 74
T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness
Valentina Bardelli, Silvia Arniani, Valentina Pierini, et al.
Genes (2021) Vol. 12, Iss. 8, pp. 1118-1118
Open Access | Times Cited: 73
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome
Omer Schwartzman, Angela Maria Savino, Michael Gombert, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 20
Open Access | Times Cited: 69
Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
Deborah Bongiovanni, Valentina Saccomani, Erich Piovan
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 9, pp. 1904-1904
Open Access | Times Cited: 63
The Biology of B-Progenitor Acute Lymphoblastic Leukemia
Kathryn G. Roberts, Charles G. Mullighan
Cold Spring Harbor Perspectives in Medicine (2019) Vol. 10, Iss. 7, pp. a034835-a034835
Open Access | Times Cited: 61
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia
Koichi Oshima, Junfei Zhao, Pablo Pérez‐Durán, et al.
Nature Cancer (2020) Vol. 1, Iss. 11, pp. 1113-1127
Open Access | Times Cited: 57
Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia
Krzysztof Jędraszek, Marta Malczewska, Karolina Parysek-Wójcik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3067-3067
Open Access | Times Cited: 28
Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia
Elizabeth A. Raetz, Deepa Bhojwani, Meenakshi Devidas, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. S6
Open Access | Times Cited: 17
Role of SHP2 in hematopoiesis and leukemogenesis
Ruchi Pandey, Mallika Saxena, Reuben Kapur
Current Opinion in Hematology (2017) Vol. 24, Iss. 4, pp. 307-313
Open Access | Times Cited: 59
Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer
Cristina Raimondi, Chiara Nicolazzo, Francesca Belardinilli, et al.
Cancers (2019) Vol. 11, Iss. 1, pp. 42-42
Open Access | Times Cited: 48
Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL
Chelsea L. Dieck, Adolfo A. Ferrando
Blood (2019) Vol. 133, Iss. 21, pp. 2263-2268
Open Access | Times Cited: 47
Molecular markers in ALL: Clinical implications
Shunsuke Kimura, Charles G. Mullighan
Best Practice & Research Clinical Haematology (2020) Vol. 33, Iss. 3, pp. 101193-101193
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top